(R) -HTS-3
(R) -HTS-3 is an lysophosphatidylcholine acyltransferase 3 (LPCAT3) inhibitor, with an IC50 of 0.09 μM. (R) -HTS-3 suppresses the C20:4 content of PE, PC, and PS, while promoting a correspondingelevation in C22:4 phospholipids and a paradoxical increase in C20:4 phosphatidylinositol (PI) lipids[1].
Product Specifications
CAS Number
[2771208-83-2]
UNSPSC
12352005
Target
Ferroptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/r-hts-3.html
Purity
99.29
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(F)=CC(F)=C1)NC[C@@H](C2=CC=CC=C2)N(C)C
Molecular Formula
C17H18F2N2O
Molecular Weight
304.33
References & Citations
[1]Alex Reed, et al. LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis. ACS Chem Biol. 2022 Jun 17;17 (6) :1607-1618.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
U4101-01A-PE 200 µL
USP20, NT (Ubiquitin Carboxyl-terminal Hydrolase 20, Ubiquitin Thiolesterase 20, Ubiquitin-specific-processing Protease 20, Deubiquitinating Enzyme 20, VHL-interacting Deubiquitinating Enzyme 2, hVDU2, KIAA1003, LSFR3A, VDU2) (PE) discontinued
Ask
View Details 